Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
19
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Batycky Alka | Director | 2 | $0 | $0 | 2024-05-23 |
| Cataldi Fabio | Chief Medical Officer | 7 | $0 | $0 | 2024-05-23 |
| Garabedian Christopher Nishan | Director | 6 | $0 | $0 | 2024-05-23 |
| Callori Fred | Director | 7 | $0 | $0 | 2024-05-23 |
| Oakes Gregory | Chief Executive Officer | 6 | $0 | $0 | 2024-05-23 |
| Adsett Roger | Director | 6 | $0 | $0 | 2024-05-23 |
| Girao Tiago | Director | 7 | $0 | $0 | 2024-05-23 |
| MAYLEBEN TIMOTHY M | Interim CEO | 6 | $0 | $0 | 2024-05-23 |
| Truesdell Patrick | Vice President and Controller | 2 | $0 | $0 | 2023-02-28 |
| Bassaganya-Riera Josep | 10% Owner | 26 | $0 | $3.07M | 2023-02-28 |
| Perceptive Xontogeny Venture Fund, LP | 10% Owner | 2 | $16.69M | $0 | 2023-01-10 |
| RTW INVESTMENTS, LP | 10% Owner | 4 | $10.00M | $207.0K | 2022-09-23 |
| BITAR PATRICIA L | Interim CFO | 1 | $0 | $0 | 2021-12-17 |
| Xontogeny, LLC | Director | 1 | $0 | $0 | 2021-08-27 |
| EDELMAN JOSEPH | Director | 1 | $0 | $0 | 2021-08-27 |
| Chauhan Jyoti | ED, Global Clinical Operations | 3 | $0 | $0 | 2021-07-26 |
| Poukalov Konstantin | Director, 10% Owner | 10 | $23.21M | $0 | 2021-02-09 |
| PERCEPTIVE ADVISORS LLC | Director, 10% Owner | 17 | $23.21M | $0 | 2021-02-09 |
| Hontecillas Raquel | Chief Scientific Officer | 1 | $0 | $0 | 2021-02-03 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Oakes Gregory | Chief Executive Officer | D To issuer deriv | 2024-05-23 | 2024-05-23 | 167,724 | — | $0 | 0 | SEC↗ |
| Oakes Gregory | Chief Executive Officer | D To issuer deriv | 2024-05-23 | 2024-05-23 | 47,529 | — | $0 | 0 | SEC↗ |
| Oakes Gregory | Chief Executive Officer | D To issuer deriv | 2024-05-23 | 2024-05-23 | 54,454 | — | $0 | 0 | SEC↗ |
| Cataldi Fabio | Chief Medical Officer | D To issuer deriv | 2024-05-23 | 2024-05-23 | 48,813 | — | $0 | 0 | SEC↗ |
| Cataldi Fabio | Chief Medical Officer | D To issuer deriv | 2024-05-23 | 2024-05-23 | 18,449 | — | $0 | 0 | SEC↗ |
| Cataldi Fabio | Chief Medical Officer | D To issuer deriv | 2024-05-23 | 2024-05-23 | 39,999 | — | $0 | 0 | SEC↗ |
| Garabedian Christopher Nishan | Director | D To issuer deriv | 2024-05-23 | 2024-05-23 | 1,800 | — | $0 | 0 | SEC↗ |
| Garabedian Christopher Nishan | Director | D To issuer deriv | 2024-05-23 | 2024-05-23 | 1,800 | — | $0 | 0 | SEC↗ |
| Garabedian Christopher Nishan | Director | D To issuer deriv | 2024-05-23 | 2024-05-23 | 1,800 | — | $0 | 0 | SEC↗ |
| Adsett Roger | Director | D To issuer deriv | 2024-05-23 | 2024-05-23 | 3,600 | — | $0 | 0 | SEC↗ |
| Adsett Roger | Director | D To issuer deriv | 2024-05-23 | 2024-05-23 | 1,800 | — | $0 | 0 | SEC↗ |
| Adsett Roger | Director | D To issuer deriv | 2024-05-23 | 2024-05-23 | 1,800 | — | $0 | 0 | SEC↗ |
| Batycky Alka | Director | D To issuer deriv | 2024-05-23 | 2024-05-23 | 3,600 | — | $0 | 0 | SEC↗ |
| Callori Fred | Director | D To issuer deriv | 2024-05-23 | 2024-05-23 | 1,800 | — | $0 | 0 | SEC↗ |
| Callori Fred | Director | D To issuer deriv | 2024-05-23 | 2024-05-23 | 1,800 | — | $0 | 0 | SEC↗ |
| Callori Fred | Director | D To issuer deriv | 2024-05-23 | 2024-05-23 | 1,800 | — | $0 | 0 | SEC↗ |
| Girao Tiago | Director | D To issuer deriv | 2024-05-23 | 2024-05-23 | 1,800 | — | $0 | 0 | SEC↗ |
| Girao Tiago | Director | D To issuer deriv | 2024-05-23 | 2024-05-23 | 1,800 | — | $0 | 0 | SEC↗ |
| Girao Tiago | Director | D To issuer deriv | 2024-05-23 | 2024-05-23 | 1,800 | — | $0 | 0 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | D To issuer deriv | 2024-05-23 | 2024-05-23 | 1,800 | — | $0 | 0 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | D To issuer deriv | 2024-05-23 | 2024-05-23 | 1,800 | — | $0 | 0 | SEC↗ |
| Oakes Gregory | Chief Executive Officer | A Award deriv | 2024-02-29 | 2024-03-04 | 54,454 | — | $0 | 54,454 | SEC↗ |
| Cataldi Fabio | Chief Medical Officer | A Award deriv | 2024-02-29 | 2024-03-04 | 21,138 | — | $0 | 21,138 | SEC↗ |
| Batycky Alka | Director | A Award deriv | 2023-05-30 | 2023-06-01 | 3,600 | — | $0 | 3,600 | SEC↗ |
| Adsett Roger | Director | A Award deriv | 2023-05-23 | 2023-05-24 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Callori Fred | Director | A Award deriv | 2023-05-23 | 2023-05-24 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Garabedian Christopher Nishan | Director | A Award deriv | 2023-05-23 | 2023-05-24 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Girao Tiago | Director | A Award deriv | 2023-05-23 | 2023-05-24 | 18,000 | — | $0 | 18,000 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | A Award deriv | 2023-05-23 | 2023-05-24 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Truesdell Patrick | Vice President and Controlle | A Award deriv | 2023-02-28 | 2023-03-02 | 99,600 | — | $0 | 99,600 | SEC↗ |
| Truesdell Patrick | Vice President and Controlle | A Award deriv | 2023-02-28 | 2023-03-02 | 99,600 | — | $0 | 99,600 | SEC↗ |
| Oakes Gregory | Chief Executive Officer | A Award deriv | 2023-02-28 | 2023-03-02 | 475,300 | — | $0 | 475,300 | SEC↗ |
| Cataldi Fabio | Chief Medical Officer | A Award deriv | 2023-02-28 | 2023-03-02 | 184,500 | — | $0 | 184,500 | SEC↗ |
| Cataldi Fabio | Chief Medical Officer | A Award deriv | 2023-02-28 | 2023-03-02 | 276,750 | — | $0 | 276,750 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | S Sale | 2023-02-28 | 2023-03-02 | 786,299 | — | $0 | 0 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | S Sale | 2023-02-28 | 2023-03-02 | 500,000 | — | $0 | 0 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | S Sale | 2023-02-28 | 2023-03-02 | 496,527 | — | $0 | 0 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | S Sale | 2023-02-28 | 2023-03-02 | 3,470,736 | — | $0 | 0 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | S Sale | 2023-02-28 | 2023-03-02 | 467,306 | — | $0 | 0 | SEC↗ |
| Perceptive Xontogeny Venture F | 10% Owner | P Buy deriv | 2023-01-10 | 2023-01-11 | 3,636,363 | $0.54 | $1.96M | 3,636,363 | SEC↗ |
| Perceptive Xontogeny Venture F | 10% Owner | P Buy deriv | 2023-01-10 | 2023-01-11 | 27,272,727 | $0.54 | $14.73M | 27,272,727 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | S Sale | 2022-09-23 | 2022-09-27 | 300,000 | $0.69 | $207.0K | 3,975,722 | SEC↗ |
| Cataldi Fabio | Chief Medical Officer | A Award deriv | 2022-09-05 | 2022-09-07 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | G Gift | 2022-08-05 | 2022-08-09 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | G Gift | 2022-08-05 | 2022-08-09 | 500,000 | — | $0 | 3,494,208 | SEC↗ |
| Oakes Gregory | Chief Executive Officer | A Award deriv | 2022-06-20 | 2022-06-22 | 1,677,251 | — | $0 | 1,677,251 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | A Award deriv | 2022-06-17 | 2022-06-22 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Adsett Roger | Director | A Award deriv | 2022-06-07 | 2022-06-09 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Girao Tiago | Director | A Award deriv | 2022-06-07 | 2022-06-09 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Garabedian Christopher Nishan | Director | A Award deriv | 2022-06-07 | 2022-06-09 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Callori Fred | Director | A Award deriv | 2022-06-07 | 2022-06-09 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Garabedian Christopher Nishan | Director | A Award deriv | 2022-05-16 | 2022-05-18 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Girao Tiago | Director | A Award deriv | 2022-05-16 | 2022-05-18 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Callori Fred | Director | A Award deriv | 2022-05-16 | 2022-05-18 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Adsett Roger | Director | A Award deriv | 2022-03-08 | 2022-03-10 | 36,000 | — | $0 | 36,000 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | S Sale | 2021-12-20 | 2021-12-20 | 33,194 | $4.75 | $157.7K | 4,994,208 | SEC↗ |
| MAYLEBEN TIMOTHY M | Interim CEO | A Award deriv | 2021-12-17 | 2021-12-21 | 253,485 | — | $0 | 253,485 | SEC↗ |
| BITAR PATRICIA L | Interim CFO | A Award deriv | 2021-12-17 | 2021-12-21 | 87,513 | — | $0 | 87,513 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | S Sale | 2021-12-17 | 2021-12-20 | 36,000 | $4.84 | $174.2K | 5,027,402 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | S Sale | 2021-12-16 | 2021-12-20 | 24,301 | $5.11 | $124.2K | 5,063,402 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | G Gift | 2021-12-16 | 2021-12-20 | 58,651 | — | $0 | 5,087,703 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | S Sale | 2021-12-15 | 2021-12-15 | 43,000 | $5.02 | $215.9K | 5,146,354 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | S Sale | 2021-12-14 | 2021-12-15 | 42,000 | $5.10 | $214.2K | 5,189,354 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 40,000 | $5.37 | $214.8K | 5,231,354 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | S Sale | 2021-12-10 | 2021-12-10 | 40,000 | $5.77 | $230.8K | 5,271,354 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | S Sale | 2021-12-09 | 2021-12-10 | 11,162 | $6.26 | $69.9K | 5,311,354 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | S Sale | 2021-12-08 | 2021-12-08 | 25,530 | $6.65 | $169.8K | 5,322,516 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | S Sale | 2021-12-07 | 2021-12-08 | 42,000 | $6.58 | $276.4K | 5,348,046 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | S Sale | 2021-12-06 | 2021-12-08 | 36,000 | $6.17 | $222.1K | 5,390,046 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | S Sale | 2021-12-03 | 2021-12-03 | 36,000 | $6.15 | $221.4K | 7,295,054 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | G Gift | 2021-12-03 | 2021-12-03 | 934,504 | — | $0 | 6,360,550 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | G Gift | 2021-12-03 | 2021-12-03 | 934,504 | — | $0 | 5,426,046 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | S Sale | 2021-12-02 | 2021-12-03 | 29,861 | $6.45 | $192.6K | 7,331,054 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | S Sale | 2021-12-01 | 2021-12-03 | 32,237 | $7.01 | $226.0K | 7,360,915 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | S Sale | 2021-11-30 | 2021-12-01 | 35,000 | $7.06 | $247.1K | 7,393,152 | SEC↗ |
| Bassaganya-Riera Josep | 10% Owner | S Sale | 2021-11-29 | 2021-12-01 | 15,430 | $7.58 | $117.0K | 7,428,152 | SEC↗ |
| Callori Fred | Director | A Award deriv | 2021-08-27 | 2021-08-31 | 36,000 | — | $0 | 36,000 | SEC↗ |
| EDELMAN JOSEPH | Director | A Award deriv | 2021-08-27 | 2021-08-31 | 25,291 | — | $0 | 25,291 | SEC↗ |
| Xontogeny, LLC | Director | A Award deriv | 2021-08-27 | 2021-08-31 | 10,709 | — | $0 | 10,709 | SEC↗ |
| Chauhan Jyoti | ED, Global Clinical Operatio | M Exercise deriv | 2021-07-26 | 2021-11-18 | 118,054 | — | $0 | 155,681 | SEC↗ |
| Chauhan Jyoti | ED, Global Clinical Operatio | M Exercise | 2021-07-26 | 2021-11-18 | 118,054 | $1.86 | $219.6K | 209,299 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | A Award deriv | 2021-05-13 | 2021-05-17 | 36,000 | — | $0 | 36,000 | SEC↗ |
| Girao Tiago | Director | A Award deriv | 2021-04-08 | 2021-04-12 | 36,000 | — | $0 | 36,000 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | Director, 10% Owner | P Buy | 2021-02-09 | 2021-02-09 | 34,951 | $14.60 | $510.3K | 7,299,751 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | Director, 10% Owner | P Buy | 2021-02-09 | 2021-02-09 | 64,730 | $13.80 | $893.3K | 7,264,800 | SEC↗ |
| Poukalov Konstantin | Director, 10% Owner | P Buy | 2021-02-09 | 2021-02-09 | 34,951 | $14.60 | $510.3K | 14,869,915 | SEC↗ |
| Poukalov Konstantin | Director, 10% Owner | P Buy | 2021-02-09 | 2021-02-09 | 64,730 | $13.80 | $893.3K | 14,834,964 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | C Conversion deriv | 2021-02-08 | 2021-02-08 | 3,650,722 | — | $0 | 0 | SEC↗ |
| Poukalov Konstantin | Director, 10% Owner | C Conversion deriv | 2021-02-08 | 2021-02-08 | 7,486,190 | — | $0 | 0 | SEC↗ |
| Poukalov Konstantin | Director, 10% Owner | C Conversion deriv | 2021-02-08 | 2021-02-08 | 5,883,538 | — | $0 | 0 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2021-02-08 | 2021-02-08 | 2,941,769 | — | $0 | 0 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2021-02-08 | 2021-02-08 | 2,857,795 | — | $0 | 0 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2021-02-08 | 2021-02-08 | 2,857,795 | — | $0 | 0 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2021-02-08 | 2021-02-08 | 2,941,769 | — | $0 | 0 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2021-02-08 | 2021-02-08 | 1,770,600 | — | $0 | 0 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | C Conversion | 2021-02-08 | 2021-02-08 | 3,650,722 | — | $0 | 4,275,722 | SEC↗ |
| Poukalov Konstantin | Director, 10% Owner | C Conversion | 2021-02-08 | 2021-02-08 | 13,369,728 | — | $0 | 13,369,728 | SEC↗ |
| Poukalov Konstantin | Director, 10% Owner | P Buy | 2021-02-08 | 2021-02-08 | 1,250,000 | $16.00 | $20.00M | 14,619,728 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | Director, 10% Owner | C Conversion | 2021-02-08 | 2021-02-08 | 2,857,795 | — | $0 | 5,799,564 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | Director, 10% Owner | C Conversion | 2021-02-08 | 2021-02-08 | 2,941,769 | — | $0 | 2,941,769 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | Director, 10% Owner | C Conversion | 2021-02-08 | 2021-02-08 | 1,770,600 | — | $0 | 1,770,600 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | Director, 10% Owner | P Buy | 2021-02-08 | 2021-02-08 | 1,250,000 | $16.00 | $20.00M | 7,049,564 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | Director, 10% Owner | C Conversion | 2021-02-08 | 2021-02-08 | 2,857,795 | — | $0 | 5,799,564 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | Director, 10% Owner | C Conversion | 2021-02-08 | 2021-02-08 | 2,941,769 | — | $0 | 2,941,769 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | Director, 10% Owner | P Buy | 2021-02-08 | 2021-02-09 | 1,771 | $13.10 | $23.2K | 7,200,070 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | Director, 10% Owner | P Buy | 2021-02-08 | 2021-02-09 | 86,671 | $12.53 | $1.09M | 7,198,299 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | Director, 10% Owner | P Buy | 2021-02-08 | 2021-02-09 | 34,611 | $11.38 | $393.9K | 7,111,628 | SEC↗ |
| Poukalov Konstantin | Director, 10% Owner | P Buy | 2021-02-08 | 2021-02-09 | 1,771 | $13.10 | $23.2K | 14,770,234 | SEC↗ |
| Poukalov Konstantin | Director, 10% Owner | P Buy | 2021-02-08 | 2021-02-09 | 86,671 | $12.53 | $1.09M | 14,768,463 | SEC↗ |
| Poukalov Konstantin | Director, 10% Owner | P Buy | 2021-02-08 | 2021-02-09 | 34,611 | $11.38 | $393.9K | 14,681,792 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | Director, 10% Owner | P Buy | 2021-02-05 | 2021-02-09 | 27,453 | $11.14 | $305.8K | 7,077,017 | SEC↗ |
| Poukalov Konstantin | Director, 10% Owner | P Buy | 2021-02-05 | 2021-02-09 | 27,453 | $11.14 | $305.8K | 14,647,181 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | P Buy | 2021-02-04 | 2021-02-08 | 625,000 | $16.00 | $10.00M | 625,000 | SEC↗ |
| Chauhan Jyoti | ED, Global Clinical Operatio | A Award deriv | 2021-02-03 | 2021-02-03 | 250,604 | — | $0 | 250,604 | SEC↗ |
| Hontecillas Raquel | Chief Scientific Officer | A Award deriv | 2021-02-03 | 2021-02-03 | 250,604 | — | $0 | 250,604 | SEC↗ |